Cimerli (ranibizumab-eqrn) - Amneal, Formycon, Coherus Biosci, Teva
Hyrimoz (adalimumab-adaz) - Sandoz
https://www.globenewswire.com/news-release/2024/10/30/2971385/0/en/Sandoz-reports-third-quarter-and-nine-month-2024-sales.html
 
Nov 3, 2024
 
Prev Next